• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION XXL ESOPHAGEAL; DILATOR, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION XXL ESOPHAGEAL; DILATOR, ESOPHAGEAL Back to Search Results
Model Number 23375
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/19/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the balloon burst.The 79% stenosed target lesion was located in the severely tortuous and severely calcified left common iliac vein and external iliac vein.During the procedure, after an 18x90 wallstent was placed, a 16-6/5.8/75 xxl esophageal balloon was placed just distal of proximal end of the stent for post-dilatation.However, during the first inflation at 3 atmospheres for 2 seconds, the balloon burst.The device was completely removed, and the procedure was completed with another of the same device.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the complaint device was received for product analysis.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.Blood observed inside the balloon is indicative of a device leak.A balloon pinhole located approximately 3mm distal of the distal markerband was identified.The rated burst pressure for this device is 5 atmospheres as per specification.A visual and tactile examination identified no kinks or damage to the shaft of the device.A visual examination identified no issues with the tip of the device.His concludes the product analysis.
 
Event or Problem Description
It was reported that the balloon burst.The 79% stenosed target lesion was located in the severely tortuous and severely calcified left common iliac vein and external iliac vein.During the procedure, after an 18x90 wallstent was placed, a 16-6/5.8/75 xxl esophageal balloon was placed just distal of proximal end of the stent for post-dilatation.However, during the first inflation at 3 atmospheres for 2 seconds, the balloon burst.The device was completely removed, and the procedure was completed with another of the same device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XXL ESOPHAGEAL
Common Device Name
DILATOR, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19011008
Report Number2124215-2024-18978
Device Sequence Number14396003
Product Code KNQ
UDI-Device Identifier08714729163114
UDI-Public08714729163114
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/16/2026
Device Model Number23375
Device Catalogue Number23375
Device Lot Number0032027192
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/19/2024
Supplement Date Received by Manufacturer04/16/2024
Initial Report FDA Received Date04/01/2024
Supplement Report FDA Received Date04/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/17/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-